Current Affairs - Technology - Discussion

Researchers from IIT-Guwahati, in collaboration with the Bose Institute, Kolkata, developed an innovative injectable hydrogel designed for localized cancer treatment, particularly breast cancer therapy. This hydrogel is composed of ultra-short peptides and is sensitive to glutathione, abundant in tumour cells, allowing precise drug activation. Unlike traditional chemotherapy, which causes systemic side effects, this hydrogel targets tumours directly, reducing harm to healthy cells. The research, led by Debapratim Das (IIT-G) and published in Materials Horizons, offers a breakthrough approach to cancer treatment, emphasizing precision and minimal invasiveness.